These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Flow Cytometric Assessment of CD26-Positive Leukemic Stem Cells: A Rapid and Valuable Tool in the Diagnosis and Follow-Up of Chronic Myeloid Leukemia. Kana S; John S; Basu D; Kar R; Nachiappa Ganesh R; Dubashi B Cureus; 2024 Mar; 16(3):e56944. PubMed ID: 38665755 [TBL] [Abstract][Full Text] [Related]
10. Leukemia Stem Cells as a Potential Target to Achieve Therapy-Free Remission in Chronic Myeloid Leukemia. Ito K; Ito K Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830976 [TBL] [Abstract][Full Text] [Related]
11. CD26 expression on circulating CD34+/CD38- progenitor population is a specific and reliable tool for the rapid flow cytometric diagnosis of chronic myeloid leukemia-A single-center validation study. Rahman K; Singh MK; Chandra D; Gupta R; Sarkar MK; Gupta P; Gupta A; Yadav S; Kashyap R; Nityanand S Int J Lab Hematol; 2022 Jun; 44(3):524-530. PubMed ID: 35315228 [TBL] [Abstract][Full Text] [Related]
12. Peripheral blood CD26 positive leukemic stem cells as a possible diagnostic and prognostic marker in chronic myeloid leukemia. Ebian HF; Abdelnabi AM; Abdelazem AS; Khamis T; Fawzy HM; Hussein S Leuk Res Rep; 2022; 17():100321. PubMed ID: 35602932 [TBL] [Abstract][Full Text] [Related]
14. CD150(-) Side Population Defines Leukemia Stem Cells in a BALB/c Mouse Model of CML and Is Depleted by Genetic Loss of SIRT1. Wang Z; Chen CC; Chen W Stem Cells; 2015 Dec; 33(12):3437-51. PubMed ID: 26466808 [TBL] [Abstract][Full Text] [Related]
15. Distinguishing CML LSCs from HSCs using CD26. Jiang X Blood; 2014 Jun; 123(25):3851-2. PubMed ID: 24948622 [TBL] [Abstract][Full Text] [Related]
16. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Zhang B; Nguyen LXT; Li L; Zhao D; Kumar B; Wu H; Lin A; Pellicano F; Hopcroft L; Su YL; Copland M; Holyoake TL; Kuo CJ; Bhatia R; Snyder DS; Ali H; Stein AS; Brewer C; Wang H; McDonald T; Swiderski P; Troadec E; Chen CC; Dorrance A; Pullarkat V; Yuan YC; Perrotti D; Carlesso N; Forman SJ; Kortylewski M; Kuo YH; Marcucci G Nat Med; 2018 May; 24(4):450-462. PubMed ID: 29505034 [TBL] [Abstract][Full Text] [Related]
17. Minimal Residual Disease Detection at RNA and Leukemic Stem Cell (LSC) Levels: Comparison of RT-qPCR, d-PCR and CD26+ Stem Cell Measurements in Chronic Myeloid Leukemia (CML) Patients in Deep Molecular Response (DMR). Abruzzese E; Bocchia M; Trawinska MM; Raspadori D; Bondanini F; Sicuranza A; Pacelli P; Re F; Cavalleri A; Farina M; Malagola M; Russo D; De Fabritiis P; Bernardi S Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627140 [TBL] [Abstract][Full Text] [Related]